Display search results for ** instead (4 products)
05 Nov 2020  |  Latin America
Automation and Work-at-Home Transforming the Customer Experience Outsourcing Services Market in Latin America and the Caribbean, Forecast to 2025
New Paramount Importance of Remote Interactions Spur Novel Growth Opportunities
The customer experience outsourcing (CXO) services market was significantly hit by the COVID-19 pandemic in 2020, especially when measuring revenue in US dollars. However, the negative impact was not as great as in other economic sectors, as a couple of positive trends were accelerated by the COVID-19 crisis. Social distancing regulations across th...
06 May 2020  |  South Asia, Middle East & North Africa
An Assessment of Growth Opportunities and Growth Pipelines in Light of the Pandemic
Like other economies, countries in the GCC have been rendered vulnerable by the COVID-19 pandemic. Wholesale and retail trade, transportation and storage, and finance and insurance, which accounted for nearly 50% of Dubai’s gross domestic product (GDP) in 2018, have all been affected. In the oil and gas industry, plunging jet fuel demand and high...
USD 6,750.00 save 10 %
27 Apr 2020  |  Global
Stakeholders to Focus on Resource Optimization, New Growth Segments and Cost Rationalization to Overcome Slowdown
The mushrooming corona virus outbreak in the central Chinese city of Wuhan prompted the World Health Organization (WHO) to declare a global health emergency in late January. The corona virus outbreak isn’t just a massive health crisis; it’s an economic one as well. If the pandemic is not contained by a large extent by April, the drop in consum...
USD 6,750.00 save 10 %
10 Jan 2020  |  Asia Pacific
Expedited Regulatory Reviews, Accompanied by Surging Novel Drug Pipelines and a Realigned Distribution System will Propel the Chinese Pharma Industry
With over-4000 pharmaceutical players, China is the second largest pharmaceutical industry globally. Although highly fragmented, global pharma and biopharmaceutical players such as Novartis, Novo Nordisk, and AstraZeneca, have a significant hold capturing at least 8-10Percentage of the market. The market being highly dependent on its distributor ne...
USD 9,000.00 save 10 %